Cardiovascular Systems (CSII) Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CSII shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares.
View CSII analyst ratings or view top-rated stocks.

2 analysts have issued 1 year price targets for Cardiovascular Systems' shares. Their CSII share price forecasts range from $15.00 to $25.00. On average, they expect the company's share price to reach $20.00 in the next year.
View analysts price targets for CSII or view top-rated stocks among Wall Street analysts.

Cardiovascular Systems' stock was trading at $13.62 on January 1st, 2023. Since then, CSII stock has increased by 46.8% and is now trading at $20.00.
View the best growth stocks for 2023 here.

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings data on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to the consensus estimate of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. Cardiovascular Systems's quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.23) earnings per share.

ETFs with the largest weight of Cardiovascular Systems (NASDAQ:CSII) stock in their portfolio include AltShares Merger Arbitrage ETF (ARB), IQ Merger Arbitrage ETF (MNA), AltShares Event-Driven ET (EVNT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Invesco Nasdaq Future Gen 200 ETF (QQQS), Principal Healthcare Innovators ETF (BTEC) and iShares Micro-Cap ETF (IWC).

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.01%), Brown Capital Management LLC (6.73%), Champlain Investment Partners LLC (5.45%), State Street Corp (3.96%), Water Island Capital LLC (3.79%) and Gabelli Funds LLC (2.08%). Insiders that own company stock include Alexander Rosenstein, Erik Paulsen, Jeffrey S Points, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends.

Shares of CSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CSII stock can currently be purchased for approximately $20.00.

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $843.96 million and generates $239.84 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis.

The company employs 780 workers across the globe.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.